451 related articles for article (PubMed ID: 18571645)
1. Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.
Campbell CA; Gaskin PJ; Darton J; Chiu P; Lee K; McLean PG
Eur J Pharmacol; 2008 Jul; 589(1-3):260-3. PubMed ID: 18571645
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
3. Current status of acid pump antagonists (reversible PPIs).
Wurst W; Hartmann M
Yale J Biol Med; 1996; 69(3):233-43. PubMed ID: 9165692
[TBL] [Abstract][Full Text] [Related]
4. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the gastric antisecretory activity of histamine H2-receptor antagonists by clebopride.
Fernández AG; Massingham R; Roberts DJ
Methods Find Exp Clin Pharmacol; 1988 May; 10(5):285-93. PubMed ID: 2899659
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of H+/K+ ATPase in the gastroprotective effect of Baccharis illinita DC.
Freitas CS; Baggio CH; Finau J; Anginoni M; Pizzolatti MG; Santos AR; Marques MC
J Pharm Pharmacol; 2008 Aug; 60(8):1105-10. PubMed ID: 18644203
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
Weingart J; Kunert H; Ottenjann R
Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
[TBL] [Abstract][Full Text] [Related]
9. Gastric antisecretory properties of SCH 32651.
Chiu PJ; Barnett A; Tetzloff G; Kaminski J
Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):116-27. PubMed ID: 6238577
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
Okabe S; Shimosako K; Amagase K
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
12. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
13. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
Pendleton RG; Cook PG; Shepherd-Rose A; Mangel AW
J Pharmacol Exp Ther; 1985 Apr; 233(1):64-9. PubMed ID: 2858583
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gastric acid secretion in vivo and in vitro by an inhibitor of Cl(-)-HCO3- exchanger, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid.
Horie S; Yano S; Watanabe K
J Pharmacol Exp Ther; 1993 Jun; 265(3):1313-8. PubMed ID: 8510011
[TBL] [Abstract][Full Text] [Related]
15. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
Nakano M; Kitano S; Nanri M; Kiniwa M
Eur J Pharmacol; 2011 May; 658(2-3):236-41. PubMed ID: 21349265
[TBL] [Abstract][Full Text] [Related]
16. Effect of mifentidine, a new H2-antagonist, on pentagastrin-stimulated acid secretion in healthy subjects.
Lazzaroni M; Ardizzone S; Imbimbo BP; Sangaletti O; Ghirardosi C; Bianchi Porro G
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):218-21. PubMed ID: 2884190
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
[TBL] [Abstract][Full Text] [Related]
18. Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans.
Maczka M; Kwiecień N; Obtułowicz W; Konturek SJ; Kamiński K; Oleksy J; Gabryelewicz A; Torres J
J Physiol Pharmacol; 1992 Jun; 43(2):139-48. PubMed ID: 1356519
[TBL] [Abstract][Full Text] [Related]
19. Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine.
Scarpignato C; Tramacere R; Tangwa M; Bertaccini G
Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):142-51. PubMed ID: 2864903
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of dimaprit- and pentagastrin-induced gastric acid secretion in cats by the new histamine H2 antagonist, CM 57755.
Lavezzo A; Manzoni L; Bianchetti A; Manara L
J Pharm Pharmacol; 1986 Nov; 38(11):853-6. PubMed ID: 2879021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]